1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
(
- Contribution to journal › Article
- 2017
-
Mark
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement
(
- Contribution to journal › Article
- 2015
-
Mark
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
2015) In Neurology(
- Contribution to journal › Article
-
Mark
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
(
- Contribution to journal › Article
- 2014
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
- 2013
-
Mark
Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
(
- Contribution to journal › Article
- 2012
-
Mark
Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
(
- Contribution to journal › Article
-
Mark
Large-scale replication and heterogeneity in Parkinson disease genetic loci
(
- Contribution to journal › Article
- 2011
-
Mark
Human leukocyte antigen variation and Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
VPS35 Mutations in Parkinson Disease
(
- Contribution to journal › Article